Genexine, Inc.
095700.KQ·KOSDAQ·Healthcare
2,540.00−60.00 (−2.31%)today
At close: Oct 21, 3:30 PM KST · May be delayed up to 20 min · KRW
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close2,600.00
Open2,670.00
Day range2,535.002,670.00
52-week range2,140.007,490.00
Off day high−4.87%
Off 52-week high−66.09%
Volume100.13K
Avg. volume (3M)414.47K
Market cap115.52B
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.41
Shares outstanding45.48M
Short interest—
Earnings dateAug 11, 2025 (est.)
Analyst target—
Profit margin0.00%
Against its peers
Compare in full ›| 095700.KQ | 1548.HK | ARGX | 22UA.F | 1FW2.F | 1877.HK | |
|---|---|---|---|---|---|---|
| Market cap | 115.52B | 78.27B | 55.91B | 20.35B | 22.89B | 17.65B |
| P/E (TTM) | — | — | 33.9 | — | 37.1 | — |
| Forward P/E | — | 87.5 | 25.0 | 1.8 | — | 86.2 |
| Price/book | — | 2.5 | 165.1 | 1.1 | 3.6 | 2.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −50.38% | +106.04% | +6.82% | −12.88% | +43.86% | −37.10% |
| Today | −2.31% | +2.69% | +2.22% | +1.95% | −1.42% | +3.74% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All 095700.KQ news ›Genexine, Inc. News — KRX:095700
Genexine, Inc. engages in research and development of novel immunotherapies for cancer and antibody therapies for rare diseases. Its pipeline of medicines is built upon its proprietary technologies, the hyFc and DNA vaccine platforms. The…
From articles in the 4Search news index.
In the news
1mentions in 30 days
1with it in the headline
Positivesentiment
Mentioned with
People in the coverage
Themes
Most coverage from
-
tradingview.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.